Study of SYHX1901 for moderate to severe plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This trial tests a new tablet called SYHX1901 for people with moderate to severe plaque psoriasis. It aims to see if the drug can improve skin symptoms and quality of life over several months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have had stable plaque psoriasis for at least 6 months covering 10% or more of your body surface
- Your psoriasis is considered moderate to severe (PASI score of 10 or higher and a doctor's assessment score of 3 or higher)
- You are a candidate for systemic treatment (pills or injections) or light therapy
- If you can become pregnant, you must have a negative pregnancy test and use effective birth control during the study and for 28 days after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HS-20137 for people with moderate to severe plaque psoriasis. It might help reduce skin symptoms like redness, scaling, and itching.
This study tests a new injectable medicine for people with moderate-to-severe plaque psoriasis. It aims to see if it is safe and effective at reducing symptoms like redness and scaling.
This trial tests an oral tablet (CMS-D001) for adults with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing psoriasis severity.
This trial tests an oral medication called HS-10374 for people with mild to moderate plaque psoriasis who haven't gotten enough relief from topical treatments. The study will check if the drug is safe and effective at clearing psoriasis patches.
This study tests an investigational oral medication called HS-10374 for moderate to severe plaque psoriasis. It aims to see how well it clears skin and prevents flares compared to a placebo, and if it is safe for long-term use.
This trial tests a new medication called HSK44459 for people with moderate to severe plaque psoriasis who need systemic therapy (medicine that works throughout the body). The goal is to see if it is safe and effective.
Hear when a new Moderate to Severe Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.